Mutabon Forte (Amitriptyline Hydrochloride, Perphenazine)

Amitriptyline Hydrochloride and Perphenazine, the active ingredients in Mutabon Forte, are a tricyclic antidepressant and a typical antipsychotic presented as an oral formulation for systemic use. They are indicated for major depressive disorder, depressive episodes with psychotic features, schizophrenia and other psychotic disorders. GNH USA supplies Mutabon Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mutabon Forte combines a tricyclic antidepressant and a typical antipsychotic to address mood and psychotic disorders. - Major depressive disorder: alleviates depressive symptoms and improves mood. - Depressive episodes with psychotic features: reduces both mood disturbances and psychotic symptoms. - Schizophrenia: controls hallucinations, delusions and other psychotic manifestations. - Other psychotic disorders: manages psychotic symptoms such as thought disorder and agitation.

Adverse reactions may occur with Mutabon Forte and should be monitored.

Common Side Effects: - Dry mouth - Constipation - Drowsiness or sedation - Weight gain - Orthostatic hypotension - Blurred vision

Serious or Rare Side Effects: - Cardiac arrhythmia, including QT prolongation - Seizures - Neuroleptic malignant syndrome - Severe hypotension - Torsades de pointes - Agranulocytosis or severe neutropenia

Mutabon Forte requires careful clinical oversight due to its pharmacologic profile. - Cardiac monitoring: assess ECG and heart rhythm in patients with cardiovascular disease. - Dose titration: start low and increase gradually under medical supervision. - Avoid in patients with known hypersensitivity to tricyclic antidepressants or phenothiazines. - Caution in elderly: higher risk of sedation, falls and anticholinergic effects. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Mutabon Forte can interact with several drug classes, necessitating review of concomitant therapies.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - CYP2D6 inhibitors: may increase amitriptyline levels causing toxicity. - QT‑prolonging drugs: additive risk of cardiac arrhythmias. - Anticholinergic agents: enhanced anticholinergic burden. - Alcohol: potentiates central nervous system depression.

Moderate Interactions (Monitor Closely): - Other antidepressants: potential for serotonin syndrome. - Antihypertensives: may enhance hypotensive effect. - Additional anticholinergic drugs: cumulative side‑effects such as dry mouth and constipation.